Breaking News Instant updates and real-time market news.

CBS

CBS

$48.79

-0.12 (-0.25%)

, CBS.A

$49.71

(0.00%)

11:01
08/12/19
08/12
11:01
08/12/19
11:01

CBS, Viacom deal 'includes extended contract' for Joe Ianiello, Gasparino says

Fox Business Network's Charles Gasparino said via Twitter that a reported deal between CBS (CBS) and Viacom (VIAB) includes an extended contract for CBS acting CEO Joe Ianniello. Gasparino said, "Joe would oversee all CBS branded content; he would report to Bob Bakish as an equal to together unit chiefs who report to him under the terms of the deal that execs are working to announce after the bell today but may bleed into tomorrow." Reference Link

CBS

CBS

$48.79

-0.12 (-0.25%)

CBS.A

$49.71

(0.00%)

VIA

Viacom

$33.20

-1.035 (-3.02%)

VIAB

Viacom

$29.00

-1.015 (-3.38%)

  • 05

    Sep

  • 05

    Sep

CBS CBS
$48.79

-0.12 (-0.25%)

05/06/19
BRRR
05/06/19
NO CHANGE
Target $60
BRRR
Outperform
CBS price target lowered to $60 from $72 at Barrington
Barrington analyst James Goss lowered his price target on CBS shares to $60 from $72, stating that following the company's Q1 report he believes CBS "remains steadily on a path it charted out several years ago" but he thinks a more conservative multiple is appropriate given the industry "turmoil and transformation" as well as management uncertainty. He keeps an Outperform rating on CBS shares, citing the company's high-margin retransmission revenue and success in the creation of new OTT ventures.
05/30/19
WOLF
05/30/19
UPGRADE
WOLF
Outperform
CBS upgraded to Outperform from Peer Perform at Wolfe Research
08/01/19
OTRG
08/01/19
NO CHANGE
OTRG
Broadcast and cable upfront pricing higher than expected, says OTR Global
OTR Global said its checks with U.S. media buyers and ad executives indicated that broadcast and cable networks increased upfront ad unit pricing higher than buyers expected. 2019 upfront prices were up 7%-10% year-over-year for broadcast and up 6%-9% year-over year for cable, exceeding sources' expectations of flat or slightly higher pricing, the firm noted, citing its checks.
08/09/19
08/09/19
NO CHANGE

CBS, Viacom closer to merger after agreeing to board, Bloomberg reports
CBS (CBS) and Viacom (VIAB) are near a merger deal after agreeing on the structure of the combined company's board, Nabila Ahmed and Gerry Smith of Bloomberg report, citing people familiar with the matter. The companies are still negotiating the exchange ratio of the potential all-stock merger, which could delay an announcement, sources told Bloomberg. Shari Redstone could become chairman of the combined entity, they added.
CBS.A
$49.71

(0.00%)

VIA Viacom
$33.20

-1.035 (-3.02%)

04/01/19
BNCH
04/01/19
NO CHANGE
Target $18
BNCH
Buy
Chicken Soup may now be one of hottest small properties in media, says Benchmark
Benchmark analyst Daniel Kurnos said Chicken Soup for the Soul (CSSE) "shocked" by announcing a joint venture with Sony (SNE) and "may have just become one of the hottest small properties in the media landscape" in the process. Kurnos believes that the new Crackle Plus will top Pluto TV from a content, monthly average user and total registered user standpoint, noting that Pluto was just sold to Viacom (VIAB) for $340M. Following the JV announcement, the analyst raised his price target on Chicken Soup shares to $18 from $16 and keeps a Buy rating on the stock.
04/04/19
RBCM
04/04/19
UPGRADE
RBCM
Outperform
Viacom upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Steven Cahall upgraded Viacom to Outperform from Sector Perform.
04/05/19
04/05/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bed Bath & Beyond (BBBY) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Simeon Gutman saying he believes activist intervention presents the potential for upside for the stock in the near-term. 2. Snap (SNAP) upgraded to Hold from Sell at Summit Insights. 3. Northrop Grumman (NOC) upgraded to Positive from Neutral at Susquehanna. 4. Weyerhaeuser (WY) upgraded to Overweight from Equal Weight at Stephens with analyst Mark Connelly saying the stock, which is generally viewed as an income play, has sold off on rate concerns and slower starts. 5. Viacom (VIA, VIAB) upgraded to Outperform from Sector Perform at RBC Capital with analyst Steven Cahall saying the company's "less contentious" than feared DirecTV (T) deal improves its standing and "paves the way toward merger talks" with CBS (CBS). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VIAB Viacom
$29.00

-1.015 (-3.38%)

04/08/19
LOOP
04/08/19
NO CHANGE
Target $59
LOOP
Buy
CBS Q1 to be impacted by higher content costs, says Loop Capital
Loop Capital analyst Alan Gould kept his Buy rating and $59 price target on CBS (CBS), saying that while he is lowering his Q1 earnings outlook by 3c to $1.37 due to higher programming costs at Showtime, he is keeping a positive view on the stock given its valuation of just 9-times forward earnings. The analyst adds that CBS and Viacom (VIAB) may reopen merger talks with the AT&T renewal having been completed.
04/22/19
LOOP
04/22/19
NO CHANGE
Target $65
LOOP
Buy
CBS price target raised to $65 from $59 at Loop Capital
Loop Capital analyst Alan Gould raised his price target on CBS (CBS) to $65 and kept his Buy rating, saying the stock represents the "most attractive opportunity in large-cap media." The analyst expects the resolution around the appointment of a permanent CEO by the company to lead to CBS entering merger talks with Viacom (VIAB) within 60 days, even though the board appears to be having a "difficult time attracting outside candidates due to the uncertainty of a potential merger," with its initial March 31st target date to conclude its CEO search now having passed.

TODAY'S FREE FLY STORIES

DK

Delek US

$33.35

0.555 (1.69%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Downgrade
Delek US rating change  »

Delek US downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$30.14

4.165 (16.04%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WORK

Slack Technologies

$30.81

0.315 (1.03%)

, MSFT

Microsoft

$138.77

1.52 (1.11%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Initiation
Slack Technologies, Microsoft initiated  »

Slack Technologies…

WORK

Slack Technologies

$30.81

0.315 (1.03%)

MSFT

Microsoft

$138.77

1.52 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

MSGN

MSG Networks

$14.78

-2.07 (-12.28%)

07:21
08/22/19
08/22
07:21
08/22/19
07:21
Recommendations
MSG Networks analyst commentary  »

MSG Networks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$103.11

17.54 (20.50%)

07:19
08/22/19
08/22
07:19
08/22/19
07:19
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

MSG

Madison Square Garden

$260.99

-6.38 (-2.39%)

07:19
08/22/19
08/22
07:19
08/22/19
07:19
Initiation
Madison Square Garden initiated  »

Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$108.00

9.96 (10.16%)

07:16
08/22/19
08/22
07:16
08/22/19
07:16
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 20

    Nov

COO

Cooper Companies

$332.66

0.39 (0.12%)

, ESLOY

EssilorLuxottica

$0.00

(0.00%)

07:12
08/22/19
08/22
07:12
08/22/19
07:12
Recommendations
Cooper Companies, EssilorLuxottica analyst commentary  »

Cooper Companies price…

COO

Cooper Companies

$332.66

0.39 (0.12%)

ESLOY

EssilorLuxottica

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 04

    Sep

CERN

Cerner

$71.77

0.44 (0.62%)

07:12
08/22/19
08/22
07:12
08/22/19
07:12
Upgrade
Cerner rating change  »

Cerner upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

TGT

Target

$103.11

17.54 (20.50%)

07:12
08/22/19
08/22
07:12
08/22/19
07:12
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

SLM

Sallie Mae

$8.29

0.07 (0.85%)

07:11
08/22/19
08/22
07:11
08/22/19
07:11
Recommendations
Sallie Mae analyst commentary  »

Sallie Mae added to US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ORBC

Orbcomm

$4.84

-0.055 (-1.12%)

07:10
08/22/19
08/22
07:10
08/22/19
07:10
Upgrade
Orbcomm rating change  »

Orbcomm upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSD

Clearside Biomedical

$1.27

0.09 (7.66%)

07:10
08/22/19
08/22
07:10
08/22/19
07:10
Hot Stocks
Clearside Biomedical plans to resubmit XIPERE NDA in 1Q20 »

Clearside Biomedical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

RCKT

Rocket Pharmaceuticals

$11.44

0.115 (1.02%)

07:09
08/22/19
08/22
07:09
08/22/19
07:09
Hot Stocks
Rocket Pharmaceuticals announces clearance to commence Phase 2 FANCOLEN-II trial »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

HIW

Highwoods Properties

$43.92

0.14 (0.32%)

07:09
08/22/19
08/22
07:09
08/22/19
07:09
Conference/Events
Highwoods Properties to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

MYGN

Myriad Genetics

$25.12

0.67 (2.74%)

07:08
08/22/19
08/22
07:08
08/22/19
07:08
Hot Stocks
Myriad 'applauds' USPSTF recommendation on BRCA-related cancer prevention »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 13

    Nov

KSHB

KushCo Holdings

$0.00

(0.00%)

07:08
08/22/19
08/22
07:08
08/22/19
07:08
Hot Stocks
KushCo Holdings secures $50M credit facility from Monroe Capital »

KushCo Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTRX

Retrophin

$17.39

0.3 (1.76%)

07:07
08/22/19
08/22
07:07
08/22/19
07:07
Hot Stocks
Breaking Hot Stocks news story on Retrophin »

Retrophin down 25% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRAX

Social Reality

$3.39

-0.06 (-1.74%)

07:06
08/22/19
08/22
07:06
08/22/19
07:06
Hot Stocks
Social Reality changing name to SRAX August 26th »

SRAX will formally change…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLHF

Standard Lithium

$0.00

(0.00%)

07:05
08/22/19
08/22
07:05
08/22/19
07:05
Hot Stocks
Standard Lithium completes fabrication of Phase 1, 2 of 'LiSTR' plant »

Standard Lithium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLY

Fly Leasing

$18.25

0.265 (1.47%)

07:04
08/22/19
08/22
07:04
08/22/19
07:04
Hot Stocks
Fly Leasing CEO says 'FLY continues to achieve record results' »

"FLY continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 03

    Sep

  • 05

    Sep

WDAY

Workday

$190.87

4.53 (2.43%)

, CRM

Salesforce

$147.40

1.85 (1.27%)

07:04
08/22/19
08/22
07:04
08/22/19
07:04
Initiation
Workday, Salesforce initiated  »

Workday initiated with a…

WDAY

Workday

$190.87

4.53 (2.43%)

CRM

Salesforce

$147.40

1.85 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 12

    Dec

  • 16

    Dec

CLSD

Clearside Biomedical

$1.27

0.09 (7.66%)

07:03
08/22/19
08/22
07:03
08/22/19
07:03
Hot Stocks
Breaking Hot Stocks news story on Clearside Biomedical »

Clearside Biomedical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

FLY

Fly Leasing

$18.25

0.265 (1.47%)

07:03
08/22/19
08/22
07:03
08/22/19
07:03
Hot Stocks
Breaking Hot Stocks news story on Fly Leasing »

Fly Leasing board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 03

    Sep

  • 05

    Sep

USNA

Usana

$67.47

0.43 (0.64%)

07:02
08/22/19
08/22
07:02
08/22/19
07:02
Initiation
Usana initiated  »

Usana initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.